Logo
Cedar Grove Capital Management
Search
Subscribe
Sign In
Home
Archive
Authors
Table of Contents
In the Press
Podcast
Our Fund
Contact Us
Logo
Cedar Grove Capital Management
Open Letter: Lensar (LNSR) Shareholders Should Reject Alcon's (ALC) Takeover Offer

Mar 24, 2025

•

5 min read

Open Letter: Lensar (LNSR) Shareholders Should Reject Alcon's (ALC) Takeover Offer

ALC is getting a sweetheart deal and grossly undervalues LNSR

Paul Cerro
Paul Cerro
Updates: CPRI Divestment & BBW Earnings Opportunity + HIMS Trade Idea

Mar 19, 2025

•

18 min read

Updates: CPRI Divestment & BBW Earnings Opportunity + HIMS Trade Idea

Taking a look at the CPRI trade w/ new info and why BBW is looking good after that earnings print

Paul Cerro
Paul Cerro
Earnings Update: LNSR / OWLT / GENK / DAKT + SHCO

Mar 11, 2025

•

21 min read

Earnings Update: LNSR / OWLT / GENK / DAKT + SHCO

Going over earnings for the first four companies + a quick update for SHCO

Paul Cerro
Paul Cerro
HIMS: Napoleon Begins His March Towards Russia?

Mar 3, 2025

•

4 min read

HIMS: Napoleon Begins His March Towards Russia?

Post-Q4 Earnings Commentary

Paul Cerro
Paul Cerro
LNSR: LENSAR Upside Into Global Clearance Looks Compelling
LockSimple

Feb 24, 2025

•

26 min read

LNSR: LENSAR Upside Into Global Clearance Looks Compelling

Growing procedural market share, inflecting positive FCF, and a growing recurring revenue segment

Paul Cerro
Paul Cerro
Expert Calls: Former FDA CDER & Current FDA IP Lawyer's Thoughts Compounding

Feb 18, 2025

•

63 min read

Expert Calls: Former FDA CDER & Current FDA IP Lawyer's Thoughts Compounding

Summarized notes from two lawyers on the GLP-1 shortage and compounding post-shortage

Paul Cerro
Paul Cerro
Reiterating Short: HIMS CC Data Suggests Growth Massively 'Over-Indexing' Toward GLP-1s

Feb 18, 2025

•

29 min read

Reiterating Short: HIMS CC Data Suggests Growth Massively 'Over-Indexing' Toward GLP-1s

Previous estimates for GLP-1 contribution may have been seriously underestimated

Paul Cerro
Paul Cerro
🚩Alert on GEN Restaurant Group (GENK)

Feb 7, 2025

•

12 min read

🚩Alert on GEN Restaurant Group (GENK)

Why recent information has made us question the accuracy of unit history in filings

Paul Cerro
Paul Cerro
Expert Call: FDA Lawyer's Thoughts On GLP-1 Shortage

Feb 2, 2025

•

12 min read

Expert Call: FDA Lawyer's Thoughts On GLP-1 Shortage

Notes from our conversation with an FDA lawyer with >40 years of experience

Paul Cerro
Paul Cerro
HIMS GLP-1 Shortage: The End is Nigh

Jan 27, 2025

•

24 min read

HIMS GLP-1 Shortage: The End is Nigh

An update on the semaglutide shortage + what happens after?

Paul Cerro
Paul Cerro
Load more

Cedar Grove Capital Management

Multi-strategy equity research focused on L/S, M&A Arb, and other Special Situations.

© 2026 Cedar Grove Capital Management.
beehiivPowered by beehiiv